BINDING PEPTIDES AND USES THEREOF

COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CFTR

Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors

4-ALKOXY-6-OXO-PYRIDAZINE DERIVATIVES MODULATING NLRP3

AZABICYCLIC SHP2 INHIBITORS

EP300/CBP MODULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF

DEBRIDING DRESSING FOR USE WITH NEGATIVE PRESSURE AND FLUID INSTILLATION

DRUG-COATED BALLOON DEVICE, SYSTEM, AND PROCEDURE

INJECTION OF SINGLE-STRANDED OR SELF-COMPLEMENTARY ADENO-ASSOCIATED VIRUS 9 INTO THE CEREBROSPINAL FLUID

THERAPEUTIC COMPOSITIONS INCLUDING SPN10 AND USES THEREOF

METHODS AND COMPOSITIONS FOR TREATING COVID INFECTIONS

METHODS FOR TREATING AND AMELIORATING CANCER

Formulated and/or Co-Formulated Lipid Nanocarriers Compositions Containing Toll-Like Receptor ("TLR") Agonist Prodrugs Useful In The Treatment of Cancer and Methods Thereof

CORTICOSTEROID COMPOSITIONS

PRE-IMMUNIZATION AND IMMUNOTHERAPY

NOVEL REPLICATION DEFICIENT INFLUENZA A VIRUS INDUCING HIGH LEVELS OF TYPE I INTERFERON

COMPOSITIONS, SYSTEMS, AND METHODS FOR REDUCING ELECTROSENSATION AND/OR SKIN IRRITATION

COMPOSITIONS AND METHODS FOR IMPROVING VACCINE THERAPY

COMPOSITIONS AND METHODS FOR USING COMBINATIONS OF ACTIN-BASED PEPTIDES TO MODULATE CELLULAR BIOACTIVITY

Method for Side Effect Reduction in the Use of Statins Via Physiologically Synthesized Glutathione

ENGINEERED CELLS FUNCTIONALIZED WITH IMMUNE CHECKPOINT MOLECULES AND USES THEREOF

Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions

THERAPY FOR INHIBITION OF SINGLE-STRANDED RNA VIRUS REPLICATION

GLYCAN THERAPEUTIC COMPOSITIONS AND RELATED METHODS THEREOF

COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE

METHODS AND RELATED COMPOSITIONS FOR REDUCTION OF FAT AND SKIN TIGHTENING

COMPOSITIONS AND METHODS FOR INHIBITING YAP

METHOD FOR PREVENTING OR TREATING DISEASE OR CONDITION ASSOCIATED WITH ANTITUMOR AGENT

METHODS OF TREATING CANCER WITH POZIOTINIB

INTRANASAL DHE FOR THE TREATMENT OF HEADACHE

Methods of Treating Diabetic Cardiomyopathy by Inhibiting GLUT1

PHARMACEUTICAL COMPOSITION FOR ENHANCING ANTICANCER EFFECT OF PROTAC, INCLUDING IU1-SERIES UBIQUITIN-SPECIFIC PROTEASE 14 INHIBITOR AS ACTIVE INGREDIENT

MAZINDOL COMBINATION IN THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY

METHODS OF IMPROVING RENAL FUNCTION

Transdermal Drug Delivery System

NALTREXONE COMPOSITIONS

UTIDELONE LIPOSOME COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF

COMPOSITIONS FOR ORAL MUCOADHESIVE DOSAGE FORMS

METHOD FOR PREVENTING NASOLACRIMAL DUCT OBSTRUCTION

METHOD AND COMPOSITION FOR DELIVERING A COMPOUND THROUGH A BIOLOGICAL BARRIER

VETERINARY USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS

TREATMENT AND DETECTION METHODS FOR INFLAMMATORY BOWEL DISEASE

METHODS AND COMPOSITIONS RELATED TO T-CELL ACTIVITY

METHODS OF STRATIFYING PATIENTS FOR TREATMENT WITH RETINOIC ACID RECEPTOR-ALPHA AGONISTS

POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF

EXPANSION AND USE OF EXPANDED NK CELL FRACTIONS

Bi-Specific Fusion Proteins

MONOCLONAL ANTIBODY NEO-201 FOR THE TREATMENT OF HUMAN CARCINOMAS

METHODS OF TREATING CANCERS AND ENHANCING EFFICACY OF T CELL REDIRECTING THERAPEUTICS

Immunomodulatory antibodies and methods of use thereof

IMMUNOGLOBULIN E ANTIBODY COMPOSITIONS AND METHODS OF USE

ANTI-EGFR NANOBODY AND USE THEREOF

METHODS OF USE OF ANTI-SORTILIN ANTIBODIES

METHOD FOR INHIBITING TUMOUR CELL GROWTH BASED ON CCDC112

OSTEOPONTIN MONOCLONAL ANTIBODIES FOR CANCER AND OSTEOPOROSIS IMMUNOTHERAPY

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER

ANTIMICROBIAL PEPTIDES AND METHOD OF PREVENTING OR TREATING INFECTION BY USING THE SAME

TARGETED DELIVERY OF 1,2,4,5 TETRAOXANE COMPOUNDS AND THEIR USES

HETEROCYCLIC INHIBITORS OF EGFR AND/OR HER2, FOR USE IN THE TREATMENT OF CANCER

INHIBITORS OF QPCTL AND QPCT

ERAP INHIBITORS

TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY

MCT4 inhibitors for treating disease

SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS

METHODS OF USE OF ULTRA-HIGH DOSE RATE RADIATION AND THERAPEUTIC AGENT

DRUG DELIVERY DEVICES WITH A MULTI-DISPENSING HEAD

COMPOSITIONS COMPRISING MOLECULES FOR CYSTIC FIBROSIS TREATMENT

MULTI-LIGAND DRUG CONJUGATES AND USES THEREOF

CYCLIC-AMP RESPONSE ELEMENT BINDING PROTEIN (CBP) AND/OR ADENOVIRAL E1A BINDING PROTEIN OF 300 KDA (P300) DEGRADATION COMPOUNDS AND METHODS OF USE

ANTI-VLA-4 ANTIBODIES

SYNERGISTIC EFFECT OF A FXR AGONIST AND IFN FOR THE TREATMENT OF HBV INFECTION

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF FRIEDREICH'S ATAXIA

Collagen peptide-based medicament compositions and devices and methods of production and use thereof

BACTERIOPHAGE TREATMENT FOR ACNE AND BIOFILMS

METHODS AND COMPOSITIONS FOR THERAPEUTIC SKIN TREATMENTS IN DERMATOLOGICAL PROCEDURES AFFECTING SKIN'S BARRIER

IMMUNOTHERAPY FOR CANCER

COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION AND GEOGRAPHIC ATROPHY

Methods of Treatment With an Iboga Alkaloid

METHODS OF TREATING HEMATOLOGIC CANCERS

DIPEPTIDYLPEPTIDASE 4 INHIBITION ENHANCES LYMPHOCYTE TRAFFICKING, IMPROVING BOTH NATURALLY OCCURRING TUMOR IMMUNITY AND IMMUNOTHERAPY

METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION

COMPOSITION FOR INHIBITING GROWTH OF CANCER STEM CELLS

METHODS OF DIAGNOSING AND TREATING ANXIETY DISORDER

Charged ion channel blockers and methods for use

TREATMENT OF INFECTIONS AND BIOFILM FORMATION USING A CELLULOSE SYNTHASE INHIBITOR

Dual inhibitors of TIM-3 and PD-1 pathways

COMPOUNDS FOR THE TREATMENT OF A DISEASE OR DISORDER, METHODS FOR IDENTIFYING SAID COMPOUNDS

METHODS FOR TREATING CANCER

ARTIFICIALLY SYNTHESIZED SPHINGOSINE DERIVATIVE LIPOID MONOMER AND USE OF SAME FOR DELIVERING NUCLEIC ACID

COMPOSITIONS AND METHODS FOR TREATING CANCER

METHOD OF IDENTIFYING A BIOLOGICALLY-ACTIVE COMPOSITION FROM A BIOFILM

SOLUBLE INTERLEUKIN-7 RECEPTOR (SIL7R) MODULATING THERAPY TO TREAT AUTOIMMUNE DISEASES AND CANCER

Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer

COMPOSITIONS AND METHODS FOR IMPROVING IMMUNE SYSTEM FUNCTION

TGF-BETA THERAPEUTICS FOR AGE DISEASE

NUCLEIC ACID MOLECULES AND THEIR METHODS OF USE

COMPOSITIONS AND METHODS FOR TREATING DISEASE ASSOCIATED WITH DUX4 OVEREXPRESSION

METHODS FOR TREATMENT OF VIRUS

METHODS OF TREATING HER2 POSITIVE BREAST CANCER WITH TUCATINIB IN COMBINATION WITH CAPECITABINE AND TRASTUZUMAB

Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses

IMMUNOMODULATORY ANTIBODIES AND USES THEREOF

METHOD OF MODULATING CELL PROLIFERATION

METHODS FOR SENSITIZING CANCER CELLS TO T CELL-MEDIATED KILLING BY MODULATING MOLECULAR PATHWAYS

ANTI-INTERLEUKIN-33 ANTIBODIES AND USES THEREOF

METHODS OF TREATING COMPLEMENT MEDIATED THROMBOTIC MICROANGIOPATHY USING AN ANTI-C5 ANTIBODY

USP13 INHIBITORS AND METHODS OF USE THEREOF

DIHYDROFUROPYRIDINE DERIVATIVES AS RHO- KINASE INHIBITORS

Quinolone derivatives as fibroblast growth factor receptor inhibitors

Non-Covalent Inhibitors of the Main Protease of SARS-CoV-2 and Methods of Use

AQUEOUS FORMULATIONS OF CYTOTOXIC TAXANES WITH CYCLODEXTRIN

SHORT-ACTING 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) ANALOGS INCORPORATING BENZOTHIAZOLE

SUBSTITUTED SALICYLAMIDE COMPOUNDS AND USE THEREOF

Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease

GENE THERAPY FOR NEURONAL CEROID LIPOFUSCINOSES

ANTI-DOPPEL ANTIBODY DRUG CONJUGATES

PRE-IMMUNIZATION AND IMMUNOTHERAPY

COMPOUNDS AND METHODS FOR BIOFILM DISRUPTION AND PREVENTION

Compositions and methods for treatment of homocystinuria

USE OF THYMOSIN ALPHA FOR THE TREATMENT OF SEPSIS

COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

COMPOSITIONS AND METHODS OF TREATMENT OF TUMORS EXPRESSING PUTATIVE ZIKA VIRUS RECEPTOR PROTEINS

ENGINEERED MULTICELLULAR ORGANISMS

FAT-ASSOCIATED LYMPHOID CLUSTERS AS SITES FOR TRANSPLANTATION, TISSUE REGENERATION, ORGANOGENESIS AND FUNCTION FOR MULTIPLE TISSUES

WNT AGONISTS FOR PREVENTION OF CANCER

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

LIPIDS THAT REDUCE LUNG DAMAGE, IMPROVE PULMONARY FUNCTION AND DECREASE PRO-INFLAMMATORY CYTOKINES

USE OF WEE1 KINASE INHIBITORS IN THE TREATMENT OF CANCER

NOVEL USES

Use Of 2-Phenyl-6-(1H-Imidazol-1-YL) Quinazoline For Treating Neurodegenerative Diseases, Preferably Alzheimer's Disease

Forms and Formulations Of A Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitor

LONAFARNIB FOR USE IN THE TREATMENT OF VIRAL INFECTIONS

SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES

PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE

Heterocyclic carboxylate compounds as glycolate oxidase inhibitors

USE OF TRANS-[TETRACHLOROBIS(1H-INDAZOLE)RUTHENATE(III)] FOR THE TREATMENT OF CANCER

6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-Fluoropropyl)Pyrrolidin-3-Yl]Oxyphenyl]-8,9-Dihydro-7H-Benzo[7]Annulene-2-Carboxylic Acid For Use In Metastatic Or Advanced Breast Cancer Patients

COMPOSITIONS AND METHODS USING AT LEAST ONE GLYCINE OR DERIVATIVE THEREOF, AT LEAST ONE N-ACETYLCYSTEINE OR DERIVATIVE THEREOF, AND AT LEAST ONE NICOTINAMIDE RIBOSIDE OR NAD+ PRECURSOR

TREATMENT REGIMENS WITH FIXED DOSES OF TAMIBAROTENE

CANCER TREATMENT COMPOSITION AND METHOD

Methods of treatment of cholestatic diseases

METHODS FOR TREATING CANCER

USE OF TWO-DIMENSIONAL NANOMATERIAL IN INHIBITION OF CORONAVIRUS

SUSTAINED RELEASING PARTICLE AND METHOD OF PRODUCING SUSTAINED RELEASING PARTICLE

COMPOSITIONS AND METHODS FOR TREATING DEPRESSION AND ANXIETY

NON-ANIMAL SOFTGEL CAPSULE FORMULATIONS, METHODS OF PREPARATION, AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR THE ABLATION OF NERVES

METHODS OF USING MESOTHELIN

URINARY METABOLOMIC BIOMARKERS FOR DETECTING COLORECTAL CANCER AND POLYPS

LOCALIZED THERAPY OF LOWER AIRWAYS INFLAMMATORY DISORDERS WITH PROINFLAMMATORY CYTOKINE INHIBITORS

MODULATORS OF CELL PROLIFERATION AND USES THEREOF

COMPOSITION AND METHOD FOR INHIBITING ANGIOTENSINOGEN (AGT) PROTEIN EXPRESSION

Treatment Of Endometriosis With R-Spondin 3 (RSPO3) Inhibitors

PROTEIN BIOMARKER AND USES THEREOF

MONOCLONAL ANTIBODIES AGAINST C-MET

GLYPICAN 2 AS A CANCER MARKER AND THERAPEUTIC TARGET

ANTI-CUB DOMAIN-CONTAINING PROTEIN 1 (CDCP1) ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND METHODS OF USE THEREOF

ANTI-4-1BB ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

GLUCAGON RECEPTOR BINDING PROTEINS AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS UTILIZING IDO1-DEPENDENT VASCULARIZING CELLS FOR THE TREATMENT OF PATHOLOGICAL CONDITIONS INVOLVING NEOVASCULARIZATION

METHODS OF TREATING RED BLOOD CELL DISORDERS

DOSING AND SCHEDULING REGIMEN FOR BROADLY NEUTRALIZING ANTIBODIES

THERAPEUTIC NEUTRALIZING ANTIBODIES FOR SARS-COV-2

Nucleic acids encoding peptides that block binding of a2d-1 to glutamate receptors for treating diseases and disorders

ANTI-INFECTIVE BICYCLIC PEPTIDE LIGANDS

ANTI-INFECTIVE BICYCLIC PEPTIDE LIGANDS

ANTAGONISTS OF THE ADENOSINE A2A RECEPTOR

COMPOSITIONS AND METHODS FOR INHIBITING M PRO PROTEASE ACTIVITY AND FOR PREVENTING AND TREATING SARS-COV-2 INFECTION

Bi-functional Molecules To Degrade Circulating Proteins

PROTECTED ALKYL TRYPTAMINES AND THEIR THERAPEUTIC USES

SMAC MIMETICS FOR TREATMENT OF CANCER, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITION THEREOF

SYNERGISTIC CANCER TREATMENT

SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES, SHIGA TOXIN EFFECTOR SCAFFOLDS, AND CELL-TARGETING MOLECULES FOR SITE-SPECIFIC CONJUGATION

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

SAFE AND EFFECTIVE BETA-LACTAMASE DOSING FOR MICROBIOME PROTECTION

GROWTH HORMONE ANTAGONIST AND ANTI-CANCER COMPOSITION COMBINATION THERAPY

METHODS FOR PREVENTING OR TREATING ALLERGY BY ADMINISTERING AN IL-4R ANTAGONIST

COMPOSITIONS COMPRISING CYCLOSPORIN

COMPOSITIONS AND METHODS FOR WILLIAMS SYNDROME (WS) THERAPY

DIAGNOSTIC METHODS FOR T CELL THERAPY

USE OF PLATELET RICH PLASMA COMPOSITION IN THE TREATMENT OF CARDIAC CONDUCTION ABNORMALITIES

Substituted phenyl boronic acid containing polymers and methods of use

Cancer treatment regimen using anti-parasitic compounds and gut microbiome modulating agents

Altering microbial populations and modifying microbiota

METHODS FOR TREATING AND PHARMACEUTICAL COMPOSITIONS

ANTI-INFLAMMATORY PHYTONUTRIENTS FOR USE IN THE TREATMENT OR PREVENTION OF SYNOVITIS

METHODS OF TREATING HEART FAILURE WITH PRESERVED EJECTION FRACTION EMPLOYING DAPAGLIFLOZIN AND COMPOSITIONS COMPRISING THE SAME

FUNGAL COMPOUND COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATION

INHIBITOR OF PROTEIN KINASE D FOR USE IN PREVENTION OR TREATMENT OF HYPERLIPIDEMIA

COMPOSITIONS AND METHODS RELATING TO CANCER

CANCER THERAPY

SARS-COV-2 THERAPEUTICS

METHODS OF TREATING HEMATOLOGICAL MALIGNANCY USING NANOPARTICLE MTOR INHIBITOR COMBINATION THERAPY

DIHYDROFUROPYRIDINE DERIVATIVES AS RHO- KINASE INHIBITORS

COMPOSITIONS AND METHODS FOR THE IDENTIFICATION OF COMPOUNDS THAT PROTECT AGAINST LIPOFUSCIN CYTOTOXICITY

HODGKIN LYMPHOMA THERAPY

PROCESS FOR OBTAINING A PURIFIED PSYCHOACTIVE ALKALOID SOLUTION

Standardized psychoactive alkaloid extract composition

Compositions and methods for treating pain with wogonin

MACROPHAGES/MICROGLIA IN NEURO-INFLAMMATION ASSOCIATED WITH NEURODEGENERATIVE DISEASES

USE OF PHTHALIDE COMPOUNDS IN TREATMENT OF MENINGIOMA

Compositions And Methods for Treating Acute Respiratory Distress Syndrome (ARDS) And Inflammatory Disorders Caused by Corona Viruses and Other Respiratory Pathogens or Agents That Mediate Pulmonary Injury, Inflammation or Acute Respiratory Distress, And Related Compositions and Methods for Treating and Preventing Human SARS Coronavirus Infection, COVID-19 Disease and Related Symptoms

Methods of treatment of cholestatic diseases

Methods of treatment of cholestatic diseases

Method for Treating Blood Cancers

Treatment or prevention of cardiovascular events via the administration of a colchicine derivative

USE OF CYSTEAMINE AND DERIVATIVES THEREOF TO SUPPRESS TUMOR METASTASES

Methods and compositions for modifying mucous membranes

CONTROLLED DRUG RELEASE FORMULATION

SYNTHETIC ARTIFICIAL STEM CELLS (SASC)

ORAL CAPSULE OF PARP INHIBITOR AND PREPARATION METHOD THEREOF

Treatment Method and Product for Uterine Fibroids using Purified Collagenase

NEBULIZATION FORMULATIONS FOR DELIVERY TO LOWER RESPIRATORY TRACT

Detecting Homologous Recombination Deficiencies (HRD) in Clinical Samples

Oligonucleotides reducing the amount of CD73 mRNA and CD73 protein expression

Immunomodulators Targeting MORC3 for Interferon Induction

FACTOR XII (HAGEMAN FACTOR) (F12), KALLIKREIN B, PLASMA (FLETCHER FACTOR) 1 (KLKB1), AND KININOGEN 1 (KNG1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

METHODS AND COMPOSITIONS RELATING TO BISPECIFIC ANTI-CHI3L1 ANTIBODY REAGENTS

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

HER2 ANTIBODY AND APPLICATION THEREOF

REGULATING IL-4 AND IL-13 LEVELS BY BLOCKING HIGH AFFINITY BINDING BY IL-3, IL-5 AND GM-CSF TO THEIR COMMON RECEPTOR

HUMAN CCR8 BINDERS

FGFR1 AGONISTS AND METHODS OF USE

Anti-αVβ6 antibodies and antibody-drug conjugates

DEVICE AND METHODS FOR RAPIDLY SCREENING AND TREATING CLINICAL CANCER PATIENTS WITH IMMUNOREGULATORY DRUGS

ANTI-C1S ANTIBODIES AND METHODS OF USE THEREOF

ACUTE TREATMENT AND RAPID TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES

HIGH DOSE TREATMENTS FOR ALZHEIMER'S DISEASE

MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME

Proteins for the treatment of epithelial barrier function disorders

Phosphonium Ion Channel Blockers and Methods for Use

ADENOSINE A2A AND A2B RECEPTOR DUAL ANTAGONISTS FOR IMMUNO-ONCOLOGY

MODIFIED ISOINDOLINONES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

SOLID FORMS OF A MODULATOR OF HEMOGLOBIN

HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS

TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS

Polypeptide Integrin Antagonists

Chilled Compressed Air Electric Vehicle (EV) Fast-Charge System and Method

Pyrrolobenzodiazepines and conjugates thereof

COMPOSITIONS COMPRISING CHEMERIN AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR REDUCTION OF IMMUNOGENICITY

COMPOSITIONS, ASSAYS, AND METHODS FOR TARGETING HDM2 AND HDMX TO REVERSE THE INHIBITION OF p53 IN PEDIATRIC CANCERS

COMPOSITIONS AND METHODS OF TREATING A PI3K MEDIATED DISEASE

BOTANICALS AS WNT/BETA-CATENIN ACTIVATORS, MOLECULAR PATHWAY REGULATORS, TISSUE REGENERATORS AND HEALTH BIOMARKER REGULATORS

CANCER THERAPY INVOLVING CAR-ENGINEERED T-CELLS AND PARVOVIRUS H-1

MATERIALS AND METHODS FOR INHIBITING A VIRAL INFECTION, INCLUDING A CORONAVIRUS INFECTION

CD28-TARGETING CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS, METHODS OF GENERATION AND USES THEREOF

Altering net charge on mannosylated dextrans to maximize target tissue uptake and off target competitive blocking

Methods and Compositions for Treating Leucine Rich Repeat Kinase 2 (LRRK2)-Associated Disorder or Condition

ANTIVIRAL SUPPLEMENT FORMULATIONS

RUXOLITINIB FOR THE TREATMENT OF PRURIGO NODULARIS

THERAPEUTIC COMBINATIONS INCLUDING INHIBITORS OF THE P2X4 RECEPTOR FOR TREATING AND PREVENTING PROLIFERATIVE DISORDERS

LUMINOL FOR THE PROPHYLAXIS AND THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION

Therapy for Mitochondrial Fatty Acid Beta-Oxidation and Transport Disorders

METHODS OF DIAGNOSING AND TREATING CONDUCT DISORDER

VOLUMETRIC LED ALIGNMENT AID FOR SIGHTING DEVICE

Inhibitors of Lysyl Oxidases

METHODS TO REDUCE HEMORRHAGE AND MORTALITY ON THE BATTLEFIELD AND APPLICATIONS FOR TRAUMA PATIENTS

Methods of treatment of cholestatic diseases

Methods of treatment of cholestatic diseases

METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES

METHODS OF TREATING OR PREVENTING AN ATTENTION DISORDER, COGNITIVE DISORDER, AND/OR DEMENTIA ASSOCIATED WITH A NEURODEGENERATIVE DISORDER

DELIVERY SYSTEM FOR USE IN MEDICINE

IMMUNE MODULATING PARTICLES

METHODS AND RELATED COMPOSITIONS FOR THE TREATMENT OF CANCER

METHOD FOR THE TREATMENT OF AN AUDITORY DISEASE OR CONDITION

CALCIUM HYDROXYAPATITE PARTICLES AND USE THEREOF

METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS

METHODS TO PREDICT EFFECTS OF PERIOPERATIVE ADMINISTRATION OF METHADONE TO OPTIMIZE PAIN RELIEF AND AVOID ADVERSE EFFECTS

GATA6-AS1 lncRNA FOR USE IN THERAPY

COMPOSITIONS AND METHODS FOR TREATMENT OF CARDIAC DISEASES

Reprogramming urokinase into an antibody-recruiting anticancer agent

Chimeric small molecules for the recruitment of antibodies to cancer cells

DEVELOPMENT AND APPLICATION OF COMPLEMENT INHIBITOR

FACTOR XI ANTIBODIES AND METHODS OF USE

ANTI-4-1BB ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

Use of Anti-EGFR/Anti-Met Antibody to Treat Liver Cancer

COMPOSITIONS AND METHODS FOR TARGETING AND KILLING ALPHA-V BETA-3-POSITIVE CANCER STEM CELLS (CSCS) AND TREATING DRUG RESISTANT CANCERS

ANTI-SIGLEC-9 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

Compositions Comprising an Anti-Metallothionein Antibody and a Hepatic Cell Targeting Moiety

TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES

ANTI-TAU ANTIBODIES AND METHODS OF USE

T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF

MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR OVARIAN AND UTERINE ONCOPROTECTION, AND OVARIAN RESERVE AND UTERINE PRESERVATION

Il-2 variants with reduced binding to IL-2 receptor alpha and uses thereof

HIDDEN ANTIBIOTICS IN THE HUMAN PROTEOME

BENZODIAZOLIUM COMPOUNDS AS ENAC INHIBITORS

NLRP3 MODULATORS

Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same

NLRP3 INFLAMMASOME INHIBITORS

METHODS OF TREATING EYE DISEASES

BONE MARROW-, RETICULOENDOTHELIAL SYSTEM-, AND/OR LYMPH NODE-TARGETED RADIOLABELED LIPOSOMES AND METHODS OF THEIR DIAGNOSTIC AND THERAPEUTIC USE

NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES

COMPOSITIONS COMPRISING AN ANTI-LAG-3 ANTIBODY OR AN ANTI-LAG-3 ANTIBODY AND AN ANTI-PD-1 OR ANTI-PD-L1 ANTIBODY

Polypeptide inhibitor of de novo lipogenesis in cancer cells

Topical Hyperpigmentation Compositions and Method of Use

COMPOSITIONS COMPRISING PROPIONIBACTERIUM ACNES BACTERIOPHAGES FOR TREATING ACNE

PROBIOTIC TREATMENTS FOR PARKINSON'S DISEASE

USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE